Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
Mayo Clinic in Arizona · Cedars-Sinai Medical Center · +23 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
874
total citations
- FWCI
- 26.95
- Percentile
- 100%
- References
- 24
Citations per year
Authors
27- RARobert A. KyleCorresponding
Mayo Clinic in Arizona
- BGBrian G.M. Durie
Cedars-Sinai Medical Center
- SVS. Vincent Rajkumar
Mayo Clinic in Arizona, WinnMed, Mayo Clinic
- OLOla Landgren
National Cancer Institute, National Institutes of Health
- JBJoan Bladé
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, Hospital Clínic de Barcelona
Topics & keywords
Topics
Keywords
- Monoclonal gammopathy of undetermined significance
- Multiple myeloma
- Medicine
- Asymptomatic
- Serum protein electrophoresis
- Internal medicine
- Macroglobulinemia
- AL amyloidosis
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.